2 quality ASX healthcare shares to snap up at more attractive prices

Here, we look at 2 quality ASX healthcare shares: CSL and Cochlear, to snap up at more attractive share prices following recent falls.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

ASX healthcare shares have been among the top-performing market sectors over the last 12 months. The demand for healthcare products and services continues to grow higher around the world.

In this article I will take you through two of my top ASX healthcare shares picks: CSL Limited (ASX: CSL) and Cochlear Limited (ASX: COH). Here's why they are both on my buy list right now:

CSL

CSL has evolved over the past 3 decades to become a global market leader in blood plasma research and disease treatment. The company is now a highly successful global business that provides a broad range of research treatments that are protected by product patents. This is backed by a highly efficient global production and distribution network, reaching more than 60 countries. CSL delivered a very strong 11% increase in revenue to US$4,980 million for the six months to 31 December 2019

This ASX healthcare share has also played a vital role during the coronavirus pandemic.  It recently entered into a new agreement for the development of a COVID-19 vaccine candidate.

I believe that the CSL growth story is set to continue over the next decade, driven by a strong new product development pipeline. With its share price down by around 18% on its 12-month high in February, I feel that now could be a good time to add CSL shares to your ASX portfolio.

Cochlear

Another company that appeals to me in the ASX healthcare sector right now is Cochlear.

The Cochlear share price fell heavily during the early phase of the coronavirus pandemic. Since then, it has only seen a relatively weak and partial recovery. Cochlear's shares are still down by around 25% from mid February. There has been a sharp reduction in elective surgeries in is operating markets, particularly in the United States and Western Europe. However, elective surgeries are now beginning again in some markets including Australia. I think that the significant recent reduction in the Cochlear share price provides investors with a good buying opportunity. I remain confident about Cochlear's long term future, driven by the growing demand for quality hearing products and solutions over the next few decades.

Foolish takeaway

Both CSL and Cochlear are two quality ASX healthcare shares that I think would make good buy and hold options over the next five years. I believe both are well placed to deliver above average shareholder returns during this period. With recent reductions in their share prices since the onset of the pandemic, investors have the opportunity to snap them up at more attractive prices.

Phil Harpur owns shares of Cochlear Ltd. and CSL Ltd. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. and CSL Ltd. The Motley Fool Australia has recommended Cochlear Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Share Gainers

These were the best-performing ASX 200 shares in March

These shares made their shareholders smile in March thanks to some very big gains.

Read more »

Businessman using a digital tablet with a graphical chart, symbolising the stock market.
Opinions

2 ASX shares I have been buying in 2024!

I’m a believer in the long-term outlook of these stocks.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

a young boy dressed up in a business suit and tie has a cute grin and holds two fingers up.
Opinions

2 of my top ASX 200 shares to consider buying before April

I would happily exchange dollars for these two shares right now.

Read more »